SEC Comment Letter 0000000000-23-000018 to BIOLARGO, INC. (BLGO)
BIOLARGO, INC.
Date: Jan. 3, 2023 · CIK: 0000880242 · Accession: 0000000000-23-000018
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-268973
Letter
United States securities and exchange commission logo January 3, 2023 Dennis Calvert Chief Executive Officer BioLargo, Inc. 14921 Chestnut St. Westminster, CA 92683 Re:BioLargo, Inc. Registration Statement on Form S-1 Filed December 23, 2022 File No. 333-268973 Dear Dennis Calvert: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jordan Nimitz at 202-551-5831 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services
Show Raw Text
United States securities and exchange commission logo
January 3, 2023
Dennis Calvert
Chief Executive Officer
BioLargo, Inc.
14921 Chestnut St.
Westminster, CA 92683
Re:BioLargo, Inc.
Registration Statement on Form S-1
Filed December 23, 2022
File No. 333-268973
Dear Dennis Calvert:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jordan Nimitz at 202-551-5831 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services